THERAVECTYS is a vaccine biotech company that designs and validates safe and efficient T-cell vaccines based on its proprietary lentiviral vector platform. Translating 20+ years of research on lentiviral vectors into actionable innovation, we bring a spectacular paradigm shift in vaccinology and commit to preventing and curing major chronic infections and cancers with high-impact on global health.